Clinical Trial Update: Combination of Carilizumab, Apatinib, and Radiotherapy for Advanced Mucosal Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of Carilizumab, Apatinib, and radiotherapy for advanced mucosal melanoma, which is currently not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucosal Melanoma

Drugs mentioned

• Apatinib (apatinib)
• Carilizumab (Carilizumab)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Mucosal Melanoma | Phase 2 | Status: NOT_YET_RECRUITING